The number of children in the United States with type 2 diabetes is increasing at an alarming rate. New research suggests that a drug called Mounjaro could help children as young as 10 manage the condition. This study shows that Mounjaro may lower blood sugar and support weight loss in young patients.
The Growing Problem
Type 2 diabetes was once mostly seen in adults, but now more children and teens are being diagnosed. According to the Centers for Disease Control and Prevention (CDC), the rate of diagnosis in children nearly doubled between 2002 and 2018. In 2002, about 9 children per 100,000 were diagnosed. By 2018, this number had risen to 18 per 100,000.
If current trends continue, experts warn that the number of young people with type 2 diabetes could increase from 28,000 in 2017 to 220,000 by 2060. The rising numbers are linked to factors such as unhealthy diets, sedentary lifestyles, and increasing childhood obesity.
What the Study Found
The new study, called SURPASS-PEDS, focused on children and adolescents living with type 2 diabetes. Researchers tested Mounjaro, a GLP-1-based medication currently approved for adults, to see if it was safe and effective in younger patients.
The study found that:
Mounjaro significantly reduced blood sugar levels in children.
Children also experienced weight loss, helping to improve overall health.
Improvements were seen in A1C levels, BMI, and other cardiometabolic risk factors.
The safety profile in children was generally similar to what is seen in adults.
Dr. Kenneth Custer, executive vice president at Eli Lilly, said, “Type 2 diabetes in children and teens is increasing at an alarming rate, yet treatment options are limited. This research helps us better support children and adolescents living with this condition.”
Why Early Treatment Matters
Managing type 2 diabetes early is very important. Children with high blood sugar who do not receive proper treatment may face serious health problems later in life, including:
Doctors believe that medications like Mounjaro could help prevent these complications by controlling blood sugar and supporting healthy weight management from a young age.
Eli Lilly’s Role
Eli Lilly, the manufacturer of Mounjaro, is now seeking approval to expand the drug for use in children. If approved, it could become one of the first new treatment options specifically tested for young patients with type 2 diabetes.
The company emphasizes that early intervention, combined with a healthy lifestyle, is key to managing diabetes in children. Researchers hope this will give families and doctors more tools to combat the rising rates of type 2 diabetes in the United States.
Expert Opinions
Health experts stress that treatment alone is not enough. Lifestyle changes, including a balanced diet, regular exercise, and healthy routines, are essential. Combining these habits with medications like Mounjaro may help children control diabetes effectively and live healthier lives.
Dr. Custer added, “Our study shows that Mounjaro delivered important improvements while keeping safety in mind. This gives hope to children and families struggling with type 2 diabetes.”
A missile strike on an energy facility in Russia's Belgorod area raises alarms over security and inf
The US launched strikes on missile sites and Iranian vessels in southern Iran while peace negotiatio
Sheikh Mohamed bin Zayed's debt relief initiative grants AED 834 million to help 2,339 retirees acro
Andrei Svechnikov scored the overtime winner as the Carolina Hurricanes defeated the Montreal Canadi
